Laura Smeaton

4.7k total citations
75 papers, 2.8k citations indexed

About

Laura Smeaton is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Laura Smeaton has authored 75 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 42 papers in Virology and 17 papers in Emergency Medicine. Recurrent topics in Laura Smeaton's work include HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (37 papers). Laura Smeaton is often cited by papers focused on HIV/AIDS Research and Interventions (45 papers), HIV Research and Treatment (42 papers) and HIV/AIDS drug development and treatment (37 papers). Laura Smeaton collaborates with scholars based in United States, India and Botswana. Laura Smeaton's co-authors include Shahin Lockman, Richard T. D’Aquila, Max Essex, Roger Shapiro, Gregory K. Robbins, Robert W. Shafer, Victor De Gruttola, Ibou Thior, Martin Hirsch and Thomas C. Merigan and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Laura Smeaton

73 papers receiving 2.7k citations

Peers

Countries citing papers authored by Laura Smeaton

Since Specialization

Citations

This map shows the geographic impact of Laura Smeaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Smeaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Smeaton more than expected).

Fields of papers citing papers by Laura Smeaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Smeaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Smeaton. The network helps show where Laura Smeaton may publish in the future.

Co-authorship network of co-authors of Laura Smeaton

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Smeaton. A scholar is included among the top collaborators of Laura Smeaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Smeaton. Laura Smeaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life 2025 ·Quality of Life Research ·Thiago S. Torres, (unknown), Laura Smeaton, (unknown), Dimas Alexandre Kliemann, Anchalee Avihingsanon, Cissy Kityo, (unknown), Marije Van Schalkwyk, Benjamin P. Linas, Estêvão Portela Nunes, Gregory K. Robbins, David Wyles, Susanna Naggie, Mark Sulkowski, Sandra Wagner Cardoso, Sunil S. Solomon	0
2	Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens 2023 ·Contraception ·Kimberly K. Scarsi, Laura Smeaton, Anthony T. Podany, (unknown), (unknown), Elizabeth Barr, (unknown), Sajeeda Mawlana, Khuanchai Supparatpinyo, Sivaporn Gatechompol, Emília M. Jalil, Luis Gadama, Sharlaa Badal‐Faesen, Pablo F. Belaunzarán-Zamudio, Catherine Godfrey, Susan E. Cohn, Rosie Mngqibisa	6
3	Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment 2023 ·Clinical Infectious Diseases ·(unknown), Laura Smeaton, (unknown), Debika Bhattacharya, Benjamin P. Linas, Bruce Kreter, (unknown), Sunil S. Solomon, Mark Sulkowski, Gregory K. Robbins	5
4	Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342) 2016 ·Journal of Antimicrobial Chemotherapy ·José Castillo‐Mancilla, Christina L. Aquilante, Michael F. Wempe, Laura Smeaton, Cynthia Firnhaber, (unknown), Nagalingeswaran Kumarasamy, Adriana Andrade, (unknown), Courtney V. Fletcher, Thomas Campbell, David W. Haas, Samantha MaWhinney, Peter L. Anderson	11
5	Vitamin D Insufficiency in HIV-infected Pregnant Women Receiving Antiretroviral Therapy is Not Associated With Morbidity, Mortality or Growth Impairment in Their Uninfected Infants in Botswana 2014 ·The Pediatric Infectious Disease Journal ·Kathleen M. Powis, Shahin Lockman, Laura Smeaton, Michael D. Hughes, Wafaie Fawzi, Anthony Ogwu, Sikhulile Moyo, Erik van Widenfelt, Julia von Oettingen, Joseph Makhema, Max Essex, Roger Shapiro	6
6	Immune Activation Markers in Peripartum Women in Botswana: Association with Feeding Strategy and Maternal Morbidity 2014 ·PLoS ONE ·Elizabeth S. Russell, Terence Mohammed, Laura Smeaton, (unknown), (unknown), Risa M. Hoffman, Judith S. Currier, Sikhulile Moyo, Max Essex, Shahin Lockman	4
7	Combination Antiretroviral Treatment for Women Previously Treated Only in Pregnancy 2013 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mary Vogler, Laura Smeaton, Rodney Wright, Sandra Wagner Cardoso, Jorge Sánchez, Rosa Infante, Laura Moran, Catherine Godfrey, Lisa M. Demeter, Victoria A. Johnson	4
8	Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World 2011 ·AIDS and Behavior ·Steven A. Safren, Ellen Hendriksen, Laura Smeaton, David D. Celentano, Mina C. Hosseinipour, Ronald L. Barnett, Juan V. Guanira, Timothy Flanigan, N Kumarasamy, Karin L. Klingman, Thomas Campbell	38
9	Prevalence and Clinical Associations of CXCR4-Using HIV-1 Among Treatment-Naive Subtype C-Infected Women in Botswana 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Nina Lin, Laura Smeaton, Françoise Giguel, Vladimir Novitsky, Sikhulile Moyo, Rebecca Mitchell, Joseph Makhema, Max Essex, Shahin Lockman, Daniel R. Kuritzkes	14
10	Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors 2009 ·European Journal of Clinical Pharmacology ·Todd Hulgan, John P. Donahue, Laura Smeaton, Minya Pu, Hongying Wang, Michael M. Lederman, Kimberly Y. Smith, Hernán Valdez, Christopher D. Pilcher, David W. Haas	3
11	Infant Morbidity, Mortality, and Breast Milk Immunologic Profiles among Breast‐Feeding HIV‐Infected and HIV‐Uninfected Women in Botswana 2007 ·The Journal of Infectious Diseases ·Roger Shapiro, Shahin Lockman, Soyeon Kim, Laura Smeaton, Jeremy Rahkola, Ibou Thior, C. William Wester, Claire Moffat, Peter Arimi, Patrick Ndase, Aida Asmelash, Lisa Stevens, Monty Montano, Joseph Makhema, Max Essex, Edward N. Janoff	125
12	Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection 2005 ·Journal of Medical Virology ·Jason T. Blackard, Florence Komurian-Pradel, Magali Perret, (unknown), Laura Smeaton, J. Benjamin St. Clair, Stacey Chapman, Lynn E. Taylor, Gláucia Paranhos‐Baccalà, Raymond T. Chung	27
13	Detection of Hepatitis C Virus (HCV) in Serum and Peripheral‐Blood Mononuclear Cells from HCV‐Monoinfected and HIV/HCV–Coinfected Persons 2005 ·The Journal of Infectious Diseases ·Jason T. Blackard, Laura Smeaton, Yoichi Hiasa, Norio Horiike, Morikazu Onji, Denise J. Jamieson, Irma Rodriguez, Kenneth H. Mayer, Raymond T. Chung	69
14	Pharmacogenetics of Long‐Term Responses to Antiretroviral Regimens Containing Efavirenz and/or Nelfinavir: An Adult AIDS Clinical Trials Group Study 2005 ·The Journal of Infectious Diseases ·David W. Haas, Laura Smeaton, Robert W. Shafer, Gregory K. Robbins, Gene D. Morse, Line Labbé, G. Wilkinson, David B. Clifford, Richard T. D’Aquila, Victor De Gruttola, Richard B. Pollard, Thomas C. Merigan, Martin Hirsch, Alfred L. George, John P. Donahue, Richard B. Kim	205
15	Diagnostic accuracy of chest X-rays acquired using a digital camera for low-cost teleradiology 2004 ·International Journal of Medical Informatics ·(unknown), Francine L. Jacobson, Samson Munn, Darius Jazayeri, Edward A. Nardell, David Harrison, (unknown), Lucila Ohno‐Machado, Laura Smeaton, Hamish Fraser	43
16	A Phase II Randomized Study of the Virologic and Immunologic Effect of Zidovudine + Stavudine versus Stavudine Alone and Zidovudine + Lamivudine in Patients with >300 CD4 Cells Who Were Antiretroviral Naive (ACTG 298) 2002 ·AIDS Research and Human Retroviruses ·Richard B. Pollard, Camlin Tierney, Diane V. Havlir, Pablo Tebas, Lawrence Fox, Laura Smeaton, Douglas D. Richman, Gerald Friedland	7
17	The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850) 2002 ·The Journal of Infectious Diseases ·(unknown), Laura Smeaton, John G. Gerber, Edward P. Acosta, Sally Snyder, Susan A. Fiscus, Richard R. Tidwell, Roy M. Gulick, Robert L. Murphy, Joseph J. Eron	34
18	ACTG (AIDS Clinical Trials Group) 384 2001 ·Controlled Clinical Trials ·Laura Smeaton, Victor DeGruttola, Gregory K. Robbins, Robert W. Shafer	26
19	Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy 1998 ·The Journal of Infectious Diseases ·Ian C. Marschner, Ann C. Collier, Robert W. Coombs, Richard T. D’Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David Katzenstein, Douglas D. Richman, Laura Smeaton, Stephen A. Spector, Michael S. Saag	182
20	Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy 1996 ·The Journal of Infectious Diseases ·Seth L. Welles, J. Brooks Jackson, Belinda Yen‐Lieberman, Lisa M. Demeter, Anthony J. Japour, Laura Smeaton, Victoria A. Johnson, Daniel R. Kuritzkes, Richard T. D’Aquila, (unknown), Douglas D. Richman, Richard C. Reichman, Margaret A. Fischl, Raphael Dolin, Robert W. Coombs, James O. Kahn, C. McLaren, John A. Todd, Shirley Kwok, Clyde S. Crumpacker	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact